Dermal fibroblast and extracellular matrix

Dermal fibroblasts are the primary cellular components of the dermis, tasked with the synthesis and maintenance of the extracellular matrix (ECM), a complex structural network of proteins and polysaccharides. The ECM provides the skin with mechanical strength, elasticity, and a scaffold for cell migration and signaling (Source: StatPearls). In healthy tissue, fibroblasts regulate the balance between matrix synthesis and degradation, a process vital for effective wound healing and tissue homeostasis. However, pathological activation of dermal fibroblasts leads to excessive ECM deposition, resulting in fibrotic conditions such as systemic sclerosis, keloids, and hypertrophic scarring (Source: PubMed). Conversely, the age-related decline in fibroblast function and ECM integrity contributes to skin thinning and wrinkle formation. Therapeutic approaches targeting this system include the use of retinoids to stimulate collagen synthesis, TGF-beta inhibitors to reduce fibrotic activity, and collagenase enzymes to degrade excess matrix in conditions like Dupuytren's contracture (Source: NIH). Understanding the interaction between these cells and their surrounding matrix is essential for developing treatments for both regenerative medicine and chronic inflammatory skin diseases.

Other names

Skin fibroblastsDermal ECMDermal connective tissueDermal matrix

Modulation of fibroblast activation, inhibition of TGF-beta signaling pathways, enzymatic degradation of collagen fibers, or stimulation of structural protein synthesis via retinoid receptors.